Natalizumab discontinuation is associated to a rebound of cognitive impairment in multiple sclerosis patients

被引:0
|
作者
Iaffaldano, P. [1 ]
Viterbo, R. G. [1 ]
Paolicelli, D. [1 ]
Direnzo, V. [1 ]
D'Onghia, M. [1 ]
Trojano, M. [1 ]
机构
[1] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1161
引用
收藏
页码:154 / 154
页数:1
相关论文
共 50 条
  • [1] Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
    Pietro Iaffaldano
    Rosa Gemma Viterbo
    Maria Trojano
    Journal of Neurology, 2016, 263 : 1620 - 1625
  • [2] Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
    Iaffaldano, Pietro
    Viterbo, Rosa Gemma
    Trojano, Maria
    JOURNAL OF NEUROLOGY, 2016, 263 (08) : 1620 - 1625
  • [3] Cognitive impairment rebound in multiple sclerosis patients after natalizumab discontinuation
    Iaffaldano, P.
    Viterbo, R. G.
    Direnzo, V.
    D'Onghia, M.
    Tortorella, C.
    Paolicelli, D.
    Trojano, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 532 - 532
  • [4] Catastrophic multiple sclerosis rebound after natalizumab treatment discontinuation
    Tur, C.
    Tintore, M.
    Vidal-Jordana, A.
    Rio, J.
    Wing, A. C.
    Canneti, B.
    Torres, M.
    Arevalo, M. J.
    Castillo, J.
    Galan, I.
    Horno, R.
    Vicente, M. J.
    Martin, M. I.
    Comabella, M.
    Rovira, A.
    Sastre-Garriga, J.
    Montalban, X.
    JOURNAL OF NEUROLOGY, 2013, 260 : S14 - S14
  • [5] Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?
    Borriello, G.
    Prosperini, L.
    Mancinelli, C.
    Fubelli, F.
    Gianni, C.
    Marinelli, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S228 - S228
  • [6] Natalizumab Rebound in Multiple Sclerosis
    Lee, Joshua D.
    Chen, Tychicus
    NEUROHOSPITALIST, 2022, 12 (01): : 197 - 198
  • [7] Rebound after natalizumab discontinuation
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 32 - 33
  • [8] Cyclophosphamide pulses therapy after natalizumab discontinuation in Multiple Sclerosis patients
    Capobianco, M.
    Lo Re, M.
    Sangalli, F.
    Moiola, L.
    Comi, G.
    Perini, P.
    Gallo, P.
    Danni, M.
    Provinciali, L.
    Repice, A.
    Massacesi, L.
    Patti, F.
    Messina, S.
    Laroni, A.
    Mancardi, G. L.
    Calabrese, M.
    Monaco, S.
    Pucci, E.
    Giuliani, G.
    Bertolotto, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 475 - 475
  • [9] Predicting Natalizumab Discontinuation due to Breakthrough Disease in Multiple Sclerosis Patients
    Conway, Devon
    Harris, Haleigh
    Hersh, Carrie
    Hua, Le
    NEUROLOGY, 2019, 92 (15)
  • [10] Cerebellar dysfunction is associated with cognitive impairment in patients with multiple sclerosis
    Skibina, O.
    Butzkueven, H.
    MacGregor, L.
    Velakoulis, D.
    Holmes, A.
    Spain, L.
    Adams, S.
    Kilpatrick, T.
    MULTIPLE SCLEROSIS, 2006, 12 : S33 - S34